Buy Ara-290 | ARA-290 5mg

Buy Ara-290, ARA-290 5mg. A synthetic peptide called ARA-290 (Cibinetide) is produced from erythropoietin and has strong anti-inflammatory and tissue-protective properties without promoting the generation of red blood cells. It is mainly investigated for neuropathy, inflammation, and tissue healing at a dose of 5 mg; clinical trials have shown encouraging results while keeping a clear safety profile.

• An 11-amino acid peptide called ARA-290 (Cibinetide) was created using the helix B surface of erythropoietin (EPO).
• ARA-290 specifically activates the Innate Repair Receptor (IRR), a receptor complex expressed on damaged or stressed tissues, in contrast to EPO, which increases the synthesis of red blood cells.
• Because of its design, ARA-290 can have cytoprotective, anti-inflammatory, and regenerative properties without posing the same cardiovascular concerns as EPO.

Buy Ara-290 | Characteristics

• Structure: pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser is a short peptide sequence.
• Mechanism of Action:
  • Activates IRR (heterodimer of EPO receptor + β common receptor).
  • Inhibits NF-κB, reducing pro-inflammatory cytokines (TNF-α, IL-1β, IL-6).
  • Promotes autophagy and cellular repair.
  • Encourages macrophage polarization toward the anti-inflammatory (M2) phenotype.
  • Stimulates small fiber nerve regeneration.
• Dosage Range: 5 mg is within the effective therapeutic window; clinical investigations usually utilize 2–8 mg per day.
• Safety: ARA-290 does not increase hematocrit or result in thrombotic events, in contrast to EPO.

Buy Ara-290 | Effects

• Neuroprotective: Reduces neuropathic pain by promoting the repair of tiny nerve fibers.
• Anti-inflammatory: Encourages tissue repair and inhibits inflammatory cytokines.
• Anti-apoptotic: Protects stressed cells by activating survival pathways (PI3K/Akt).
• Metabolic Support: Preliminary studies indicate that pancreatic beta cells in diabetes may be protected.

Benefits

• Neuropathy Relief: Studies demonstrate improvements in small fiber neuropathy linked to sarcoidosis and diabetic peripheral neuropathy, which lessen pain and enhance nerve function.
• Tissue Repair: Promotes cellular healing in injured tissues, such as the heart, nerves, and epithelial cells.
• Decreased Risk Profile: Offers the preventive benefits of EPO without the risky adverse effects of blood thickening.
• Potential Applications:
  • Diabetes: Beta cell protection and reduced inflammation.
  • Neuropsychiatric Research: New research points to potential advantages for mood and cognitive issues.
  • General Healing: Accelerates recovery in tissues under stress or injury.

In conclusion
At 5 mg, ARA-290 is a new therapeutic peptide that separates erythropoietin’s tissue-protective advantages from its hematological dangers. Although it is still in the experimental stage needing additional clinical validation, its neuroprotective, anti-inflammatory, and regenerative qualities make it a viable option for treating neuropathy and other inflammatory disorders.